Explore the details of the Boehringer Ingelheim Pharmaceuticals Inc. V. Granules India Limited case under case number 1:24-cv-00753 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00753
Filing Date
Jun 25, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Boehringer Ingelheim Pharma GmbH & Co. KG -
Granules India Limited -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US10034877B2
-US9486526B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jun 25, 2024Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 06/26/2024)PACER Document
Jun 25, 2024COMPLAINT FOR ANDA/PATENT INFRINGEMENT filed against Granules India Limited (Filing fee $ 405, receipt number ADEDC-4437999.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # 1 Exhibit 1-2, # 2 Civil Cover Sheet)(jfm) (Entered: 06/26/2024)PACER Document
Jun 25, 2024Summons Issued as to Granules India Limited on 6/25/2024. (jfm) (Entered: 06/26/2024)PACER Document
Jun 25, 2024Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG. for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG, Boehringer Ingelheim Pharmaceuticals Inc. (jfm) (Entered: 06/26/2024)PACER Document
Jun 25, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,486,526 B2; 10,034,877 B2. (jfm) (Entered: 06/26/2024)PACER Document
Jun 25, 2024Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No earlier than May 13, 2024. Date of Expiration of Patent: August 5, 2029.Thirty Month Stay Deadline: 11/13/2026. (jfm) (Entered: 06/26/2024)PACER Document